A detailed history of Baldwin Brothers LLC transactions in Pfizer Inc stock. As of the latest transaction made, Baldwin Brothers LLC holds 38,677 shares of PFE stock, worth $1.03 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
38,677
Previous 36,194 6.86%
Holding current value
$1.03 Million
Previous $1.01 Million 10.57%
% of portfolio
0.08%
Previous 0.08%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $68,779 - $77,941
2,483 Added 6.86%
38,677 $1.12 Million
Q2 2024

Jul 12, 2024

SELL
$25.26 - $29.6 $481,733 - $564,501
-19,071 Reduced 34.51%
36,194 $1.01 Million
Q1 2024

Apr 12, 2024

SELL
$25.89 - $29.73 $51,624 - $59,281
-1,994 Reduced 3.48%
55,265 $1.53 Million
Q4 2023

Jan 08, 2024

SELL
$26.13 - $33.94 $49,620 - $64,452
-1,899 Reduced 3.21%
57,259 $1.65 Million
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $551,948 - $645,172
-17,200 Reduced 22.53%
59,158 $1.96 Million
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $6,573 - $7,605
182 Added 0.24%
76,358 $2.8 Million
Q1 2023

Apr 21, 2023

SELL
$39.39 - $51.28 $1,733 - $2,256
-44 Reduced 0.06%
76,176 $3.11 Million
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $1.22 Million - $1.6 Million
29,308 Added 62.47%
76,220 $0
Q3 2022

Oct 14, 2022

SELL
$43.76 - $53.42 $6,126 - $7,478
-140 Reduced 0.3%
46,912 $2.05 Million
Q2 2022

Jul 18, 2022

SELL
$46.53 - $55.17 $255,915 - $303,435
-5,500 Reduced 10.47%
47,052 $2.47 Million
Q1 2022

Apr 13, 2022

BUY
$45.75 - $56.69 $722,850 - $895,702
15,800 Added 42.99%
52,552 $2.72 Million
Q4 2021

Jan 14, 2022

BUY
$41.32 - $61.25 $9,090 - $13,475
220 Added 0.6%
36,752 $2.17 Million
Q3 2021

Oct 27, 2021

SELL
$39.25 - $50.42 $12,520 - $16,083
-319 Reduced 0.87%
36,532 $1.57 Million
Q2 2021

Jul 30, 2021

SELL
$35.91 - $40.68 $4,093 - $4,637
-114 Reduced 0.31%
36,851 $1.44 Million
Q1 2021

Apr 08, 2021

SELL
$33.49 - $37.77 $108,842 - $122,752
-3,250 Reduced 8.08%
36,965 $1.34 Million
Q1 2020

Apr 15, 2020

SELL
$27.03 - $38.62 $46,032 - $65,769
-1,703 Reduced 4.06%
40,215 $1.31 Million
Q4 2019

Jan 29, 2020

BUY
$32.92 - $37.36 $21,398 - $24,284
650 Added 1.58%
41,918 $1.64 Million
Q3 2019

Oct 10, 2019

SELL
$32.49 - $42.13 $7,570 - $9,816
-233 Reduced 0.56%
41,268 $1.48 Million
Q2 2019

Jul 19, 2019

BUY
$36.98 - $41.52 $283,007 - $317,752
7,653 Added 22.61%
41,501 $1.8 Million
Q1 2019

Apr 24, 2019

BUY
$37.5 - $41.2 $273,112 - $300,059
7,283 Added 27.42%
33,848 $1.44 Million
Q4 2018

Feb 01, 2019

BUY
$38.47 - $43.86 $7,694 - $8,772
200 Added 0.76%
26,565 $1.16 Million
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $35,331 - $42,855
-1,025 Reduced 3.74%
26,365 $1.16 Million
Q2 2018

Jul 24, 2018

SELL
$32.98 - $35.16 $8,245 - $8,790
-250 Reduced 0.9%
27,390 $994,000
Q1 2018

Apr 16, 2018

SELL
$31.91 - $37.02 $34,909 - $40,499
-1,094 Reduced 3.81%
27,640 $981,000
Q4 2017

Jan 24, 2018

SELL
$33.26 - $35.29 $24,579 - $26,079
-739 Reduced 2.51%
28,734 $1.04 Million
Q3 2017

Oct 26, 2017

BUY
$31.0 - $34.15 $913,663 - $1.01 Million
29,473
29,473 $1.05 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.